Motif in T cells for the Prediction of INTeractions
T cells are a key element of the human immune system. Upon binding to antigenic peptides (called T cell epitopes), T cells can induce the death of infected cells or prime and regulate other immune cells. In cancer immunotherapy tr...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
PID2020-118529RB-I00
EXPLOTANDO LOS DETERMINANTES MOLECULARES DE LA RESPUESTA T A...
218K€
Cerrado
DevoSignGammaDelta
Tracking T cell development and TCR proximal signalling
161K€
Cerrado
EXPAND IT
EXPANDing Immune Cells and their Tumor Antigens during check...
3M€
Cerrado
MUTAEDITING
Mutation driven immunoediting of human cancer?
2M€
Cerrado
ImmunoChip
Nano-assisted digitalizing of cancer phenotyping for immunot...
2M€
Cerrado
DynOMIS
Dynamic Origins of MHC class I Selector function
195K€
Cerrado
Información proyecto MT-PoINT
Duración del proyecto: 26 meses
Fecha Inicio: 2021-04-07
Fecha Fin: 2023-06-30
Líder del proyecto
swiss aeropole SA
No se ha especificado una descripción o un objeto social para esta compañía.
Presupuesto del proyecto
191K€
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
T cells are a key element of the human immune system. Upon binding to antigenic peptides (called T cell epitopes), T cells can induce the death of infected cells or prime and regulate other immune cells. In cancer immunotherapy treatments, T cells are genetically re-engineered to recognize cancer epitopes and destroy malignant cells. Unfortunately, it still remains challenging to determine which T cells can target a specific epitope, both from a computational and experimental point of view. This limits mechanistic understanding of T-cell-mediated immunity and translational applications for disease treatments.
Thanks to advances in high-throughput sequencing technologies, sequence data of T cells coupled with their cognate epitopes are accumulating at an unprecedented pace, offering unique opportunities to develop data-driven T cell-epitope interaction predictors.
The goal of the MT-PoINT project (Motif in T cells for the Prediction of INTeractions) is to identify patterns in T cells sequences that underlie the binding specificity, interpret them at the structural level, and to develop sequence-based predictors of T cell-epitope interactions (Aim1) with a special focus on T cells targeting cancer epitopes (Aim2). My project will capitalize on a unique dataset of publicly available and in-house generated data that was not available in previous studies, and T cell sequence data from cancer patients of Lausanne University Hospital will allow me to benchmark the in-silico predictors in a clinically relevant setting.
Accurate predictions of TCR-epitope interactions can narrow down the list of T cell candidates for personalized cancer immunotherapies, and significantly accelerate cancer immunotherapy clinical developments.